fda warning letter bpc 157 compounding pharmacy An advisory committee voted Thursday to remove restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with FDA panel votes to add

FDA panel votes to add peptides to permitted list despite opposition from agency scientists FDA is moving to restrict mass marketed compounded GLP 1 products that aren't FDA approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link An FDA panel votes today and tomorrow on whether pharmacies can legally make seven peptides. A yes vote is not FDA approval. It means a pharmacy can make it, not that anyone

SKU: 61411027093 · From composequickly.com